Jupiter Neurosciences, Inc.
JUNS
$0.34
-$0.01-3.29%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -68.57% | -287.14% | -819.58% | -141.11% | -255.59% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 133.05% | 3,764.00% | 3,722.00% | 3,680.00% | 1,558.00% |
| Total Other Non-Cash Items | -63.55% | 442.82% | 181.37% | 19.41% | 2,160.61% |
| Change in Net Operating Assets | 88.39% | -118.15% | 214.92% | -168.61% | -1,665.83% |
| Cash from Operations | 35.93% | -2,610.09% | -670.42% | -1,530.37% | -2,194.10% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 371,900.00% | -- | -- | -- | -98.85% |
| Total Debt Repaid | 93.80% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -27.21% | -- | -- | -- | 5,642.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.67% | -7,807.53% | -12,841.54% | -5,162.38% | 12,219.94% |